Recent Faculty Publications

Vogel B, Mehta SR, Mehran R. Reperfusion strategies in acute myocardial infarction and multivessel disease. Nat Rev Cardiol. 2017 Jun 29.

Vanags LZ, Tan JTM, Santos M, Michael PS, Ali Z, Bilek MMM, Wise SG, Bursill CA. Plasma activated coating immobilizes apolipoprotein A-I to stainless steel surfaces in its bioactive form and enhances biocompatibility. Nanomedicine. 2017 Jun 29;13(7):2141-2150.

Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, Windecker S, Serruys PW, Kastrati A, Von Birgelen C, Kimura T, Stefanini GG, Dangas GD, Wijns W, Steg PG, Morice MC, Camenzind E, Weisz G, Smits PC, Sorrentino S, Sharma M, Farhan S, Faggioni M, Kandzari D, Galatius S, Jeger RV, Valgimigli M, Itchhaporia D, Mehta L, Kim HS, Chieffo A, Mehran R. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. JAMA Cardiol. 2017 Jun 28.

Baron SJ, Arnold SV, Wang K, Magnuson EA, Chinnakondepali K, Makkar R, Herrmann HC, Kodali S, Thourani VH, Kapadia S, Svensson L, Brown DL, Mack MJ, Smith CR, Leon MB, Cohen DJ; PARTNER 2 Investigators. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial. JAMA Cardiol. 2017 Jun 28.

Sorrentino S, Giustino G, Mehran R, Kini AS, Sharma SK, Faggioni M, Farhan S, Vogel B, Indolfi C, Dangas GD. Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents. J Am Coll Cardiol. 2017 Jun 27;69(25):3055-3066.

Kotronias RA, Kwok CS, George S, Capodanno D, Ludman PF, Townend JN, Doshi SN, Khogali SS, Généreux P, Herrmann HC, Mamas MA, Bagur R. Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017 Jun 27;6(6).

Généreux P. LOTUS Valve: Increasing the Pace of Device Iterations. JACC Cardiovasc Interv. 2017 Jun 26;10(12):1254-1256.

Rasania SP, Chamaria S, Vengrenyuk Y, Baber U, Dangas G, Mehran R, Barman N, Sweeny J, Kini A, Sharma S. Percutaneous Coronary Intervention Outcomes in Very Elderly Patients From a Single Large-Volume Tertiary Care Center, Specifically Focusing on Nonagenarians. JACC Cardiovasc Interv. 2017 Jun 26;10(12):1273-1274.

Kosmidou I, Redfors B, McAndrew T, Embacher M, Mehran R, Dizon JM, Ben-Yehuda O, Mintz GS, Stone GW. Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial. Coron Artery Dis. 2017 Jun 21.

Peppas A, Furer A, Wilson J, Yi G, Cheng Y, Van Wygerden K, Seguin C, Shibuya M, Kaluza GL, Granada JF. Preclinical in vivo long-term evaluation of the novel Mitra-Spacer technology: experimental validation in the ovine model. EuroIntervention. 2017 Jun 20;13(3):272-279.

Song L, Mintz GS, Yin D, Yamamoto MH, Chin CY, Matsumura M, Kirtane AJ, Parikh MA, Moses JW, Ali ZA, Shlofmitz RA, Maehara A. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study. EuroIntervention. 2017 Jun 20;13(3):294-302.

Chakravarty T, Søndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, Jilaihawi H, Shiota T, Abramowitz Y, Jørgensen TH, Rami T, Israr S, Fontana G, de Knegt M, Fuchs A, Lyden P, Trento A, Bhatt DL, Leon MB, Makkar RR; RESOLVE.; SAVORY Investigators.. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.Lancet. 2017 Jun 17;389(10087):2383-2392.

Bax JJ, Stone GW. Bioprosthetic surgical and transcatheter heart valve thrombosis. Lancet. 2017 Jun 17;389(10087):2352-2354.

Ertelt K, Brener SJ, Mehran R, Ben-Yehuda O, McAndrew T, Stone GW. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study). Am J Cardiol. 2017 Jun 15;119(12):1917-1923.

Redfors B, Maehara A, Witzenbichler B, Weisz G, Stuckey TD, Henry TD, McAndrew T, Mehran R, Kirtane AJ, Stone GW, Généreux P. Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation. J Invasive Cardiol. 2017 Jun 15.

Baber U, Mehran R. Improving Outcomes in High-Risk Percutaneous Coronary Interventions and Newer-Generation Drug-Eluting Stents: Good, But Not Good Enough. Cardiology. 2017 Jun 14;138(2):73-75.

Fink DL, Machluf Y, Farkash R, Weisz G, Pirogovsky A, Tal O, Dagan D, Chaiter Y. Cardiac anomalies and associated comorbidities in a large adolescent population. Int J Adolesc Med Health. 2017 Jun 14.

Sakellarios A, Bourantas CV, Papadopoulou SL, Kitslaar PH, Girasis C, Stone GW, Reiber JHC, Michalis LK, Serruys PW, de Feyter PJ, Garcia-Garcia HM, Fotiadis DI. The effect of coronary bifurcation and blood flow modelling in prediction of atherosclerotic plaque development: a Serial Computed Tomographic Coronary Angiographic study. EuroIntervention. 2017 Jun 13.

De Luca G, Smits P, Hofma SH, Di Lorenzo E, Vlachojannis GJ, Van't Hof AWJ, van Boven AJ, Kedhi E, Stone GW, Suryapranata H; Drug-Eluting Stent in Primary Angioplasty (DESERT 3) cooperation. Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials. Int J Cardiol. 2017 Jun 13.

Lembo NJ, Hatem R, Karmpaliotis D. Predictive Scores of Success in CTO PCI: There Is No Substitute for Operator Experience and Skill. JACC Cardiovasc Interv. 2017 Jun 12;10(11):1099-1101.

Zhang D, Yin D, Song C, Zhu C, Kirtane AJ, Xu B, Dou K. A randomised comparison of Conventional versus Intentional straTegy in patients with high Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion: rationale and design of the CIT-RESOLVE trial. BMJ Open. 2017 Jun 12;7(6):e016044.

Ó Hartaigh B, Gransar H, Callister T, Shaw LJ, Schulman-Marcus J, Stuijfzand WJ, Valenti V, Cho I, Szymonifka J, Lin FY, Berman DS, Chang HJ, Min JK. Development and Validation of a Simple-to-Use Nomogram for Predicting 5-, 10-, and 15-Year Survival in Asymptomatic Adults Undergoing Coronary Artery Calcium Scoring. JACC Cardiovasc Imaging. 2017 Jun 9.

Dionne PO, Poulin F, Bouchard D, Généreux P, Ibrahim R, Cartier R, Lamarche Y, Demers P. Early Hemodynamic Results in Patients With Small Aortic Annulus After Aortic Valve Replacement. Innovations (Phila). 2017 Jun 8.

Grinstein J, Rodgers D, Kalantari S, Sayer G, Kim GH, Sarswat N, Adatya S, Ota T, Jeevanandam V, Burkhoff D, Uriel N. HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump. ASAIO J. 2017 Jun 7.

Jeremias A, Kirtane AJ, Stone GW. A Test in Context: Fractional Flow Reserve: Accuracy, Prognostic Implications, and Limitations.J Am Coll Cardiol. 2017 Jun 6;69(22):2748-2758.

Parker WA, Bhatt DL, Prats J, Day JRS, Steg PG, Stone GW, Hamm CW, Mahaffey KW, Price MJ, Gibson CM, White HD, Storey RF; CHAMPION PHOENIX Investigators.. Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study. Thromb Haemost. 2017 Jun 2;117(6):1093-1100.

Stone GW. Very late scaffold thrombosis: is prolonged DAPT the answer? EuroIntervention. 2017 Jun 2;13(2):e139-e141.

Kang SJ, Yang DH, Koo HJ, Yun SC, Lee JG, Kang JW, Lim TH, Mintz GS, Park SW, Kim YH. Intravascular ultrasound-derived morphological predictors of myocardial ischemia assessed by stress myocardial perfusion computed tomography. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):E207-E216. 

Chandrasekhar J, Bansilal S, Baber U, Sartori S, Aquino M, Farhan S, Vogel B, Faggioni M, Giustino G, Ariti C, Colombo A, Chieffo A, Kini A, Saporito R, Michael Gibson C, Witzenbichler B, Cohen D, Moliterno D, Stuckey T, Henry T, Pocock S, Dangas G, Gabriel Steg P, Mehran R. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):E217-E225.

Roleder T, Karimi Galougahi K, Chin CY, Bhatti NK, Brilakis E, Nazif TM, Kirtane AJ, Karmpaliotis D, Wojakowski W, Leon MB, Mintz GS, Maehara A, Stone GW, Ali ZA. Utility of near-infrared spectroscopy for detection of thin-cap neoatherosclerosis. Eur Heart J Cardiovasc Imaging. 2017 Jun 1;18(6):663-669.

Asher E, Mansour J, Wheeler A, Kendrick D, Cunningham M, Parikh S, Zidar D, Harford T, Simon DI, Kashyap VS. Cost awareness decreases total percutaneous coronary intervention procedural cost: The SHOPPING (Show How Options in Price for Procedures Can Be Influenced Greatly) trial. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1207-1212.

Clerkin KJ, Topkara VK, Mancini DM, Yuzefpolskaya M, Demmer RT, Dizon JM, Takeda K, Takayama H, Naka Y, Colombo PC, Garan AR. The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis. J Heart Lung Transplant. 2017 Jun;36(6):633-639.

Schulman-Marcus J, Heo R, Gransar H, Suwaidi JA, Alkuwari M, Elmore K, Gomez MJ, Jayyousi A, Zirie M, Min JK, Peña JM. Subclinical atherosclerosis detected by coronary computed tomographic angiography in Qatar: a comparison between Qataris and south Asian migrants. Int J Cardiovasc Imaging. 2017 Jun;33(6):927-935.

Lee M, Généreux P, Shlofmitz R, Phillipson D, Anose BM, Martinsen BJ, Himmelstein SI, Chambers JW. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial. Cardiovasc Revasc Med. 2017 Jun;18(4):261-264.

Tamez H, Pinto DS, Kirtane AJ, Litherland C, Yeh RW, Dangas GD, Mehran R, Deliargyris EN, Ortiz G, Gibson CM, Stone GW. Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI: A Secondary Analysis of the HORIZONS-AMI Randomized Clinical Trial. JAMA Cardiol. 2017 Jun 1;2(6):673-677.

Brener SJ, Mehran R, Dangas GD, Ohman EM, Witzenbichler B, Zhang Y, Parvataneni R, Stone GW. Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials).Am J Cardiol. 2017 Jun 1;119(11):1710-1716.

Kosmidou I, Redfors B, Selker HP, Thiele H, Patel MR, Udelson JE, Magnus Ohman E, Eitel I, Granger CB, Maehara A, Kirtane A, Généreux P, Jenkins PL, Ben-Yehuda O, Mintz GS, Stone GW. Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials. Eur Heart J. 2017 Jun 1;38(21):1656-1663.

Mintz GS. Intravascular ultrasound and outcomes after drug-eluting stent implantation. Coron Artery Dis. 2017 Jun;28(4):346-352.

Gerrah R, Haller SJ, George I. Mechanical Concepts Applied in Congenital Heart Disease and Cardiac Surgery. Ann Thorac Surg. 2017 Jun;103(6):2005-2014.

Yahagi K, Ladich E, Kutys R, Mori H, Svensson LG, Mack MJ, Herrmann HC, Smith CR, Leon MB, Virmani R, Finn AV. Pathology of balloon-expandable transcatheter aortic valves. Catheter Cardiovasc Interv. 2017 Jun 1.

Harjai KJ, Grines CL, Paradis JM, Kodali S. Transcatheter aortic valve replacement: The year in review 2016. J Interv Cardiol. 2017 Jun;30(3):286.

de Castro-Filho A, Lamas ES, Meneguz-Moreno RA, Staico R, Siqueira D, Costa RA, Braga SN, Costa JR Jr, Chamié D, Abizaid A. Impact of the Occlusion Duration on the Performance of J-CTO Score in Predicting Failure of Percutaneous Coronary Intervention for Chronic Total Occlusion. J Invasive Cardiol. 2017 Jun;29(6):195-201.

Abnousi F, Sundaram V, Yong CM, Prats J, Deliargyris EN, Stone GW, Hamm CW, Steg PG, Gibson CM, White HD, Price MJ, Généreux P, Desai M, Yang L, Ding VY, Harrington RA, Bhatt DL, Mahaffey KW. Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trial. Am Heart J. 2017 Jun;188:147-155.

Selker HP, Udelson JE, Ruthazer R, D'Agostino RB, Nichols M, Ben-Yehuda O, Eitel I, Granger CB, Jenkins P, Maehara A, Patel MR, Ohman EM, Thiele H, Stone GW. Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials. Am Heart J. 2017 Jun;188:18-25. 

Baber U, Sartori S, Aquino M, Kini A, Kapadia S, Weiss S, Strauss C, Muhlestein JB, Toma C, Rao SV, DeFranco A, Poddar KL, Chandrasekhar J, Weintraub W, Henry TD, Bansilal S, Baker BA, Marrett E, Keller S, Effron M, Pocock S, Mehran R. Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study. Am Heart J. 2017 Jun;188:73-81.

Kerkmeijer LS, Farhan S, Mehran R, Dangas GD. Diabetes mellitus and multivessel coronary artery disease: an ongoing battle for an ideal treatment strategy. Ann Transl Med. 2017 Jun;5(12):261.

Song E, Jahng JW, Chong LP, Sung HK, Han M, Luo C, Wu D, Boo S, Hinz B, Cooper MA, Robertson AA, Berger T, Mak TW, George I, Schulze PC, Wang Y, Xu A, Sweeney G. Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge. Am J Transl Res. 2017 Jun 15;9(6):2723-2735.